HOME > Corporate Information > Message from the CEO

Message from the CEO

CEO Kenji Fukunaga

TRANS GENIC Inc. started its operation as a research laboratory that conducts antibody development and its contract-production service. We have been expanding the business field including contract knockout mice production, provision of genetic information to the research institutes such as universities and pharmaceutical companies, distribution of research reagents, as well as non-clinical/ clinical test service and pathological diagnosis, and are aiming to become the unique company that totally supports drug discovery.

We have achieved a sales growth of more than 20% for five consecutive fiscal terms. To promote further growth, we developed mid to long-term business planning, "Long-Term Business Planning Vision 2020" and “Medium-Term Business Planning Vision", and work diligently to achieve those goals.

Under our business philosophy of "Creating world-leading technologies", we work hard to fulfill our management principle--"Contribute to the future of medicine and healthy and affluent lives of people around the world by providing genetic information, obtained through developing bio-resources ranging from individual organisms to genomes, for basic researches and various medical and healthcare settings" with pride.
We will continue its persistent efforts to become a company that can meet the expectations of those who understand and support our goal. We hope to receive your continued support.

  • Press Releases
Contact us/Products & ServiceE-mail
  • Reproductive Technology Training
Back to Top